Wachtell, Lipton, Rosen & Katz is serving as legal advisor to Nasdaq on the transaction, while Kirkland & Ellis LLP is serving as legal advisor to...
Nasdaq’s $10.5 Billion Acquisition of Adenza from Thoma Bravo
RenaissanceRe’s $2.985 Billion Acquisition of Validus Re Business From AIG
Sidley Austin represented RenaissanceRe, while Wachtell, Lipton, Rosen & Katz and Debevoise & Plimpton represented AIG in the transaction. Paul Hastings represented Morgan Stanley. American International...
Regency Centers Corporation’s $1.4 Billion Merger With Urstadt Biddle Properties
Wachtell, Lipton, Rosen & Katz represented Regency Centers, while Hogan Lovells US represented Urstadt Biddle in the transaction. Latham & Watkins represented Eastdil Secured. Regency Centers...
Pfizer’s Acquisition of Seagen
Wachtell, Lipton, Rosen & Katz is acting as Pfizer’s legal advisor. Sullivan & Cromwell is serving as Seagen’s Board of Directors legal advisor. Skadden is advising...
BGC Partners’ Corporate Conversion Agreement
Wachtell, Lipton, Rosen & Katz advised BGC Partners on the matter. Debevoise & Plimpton advised a Joint Committee of the Board of Directors of BGC Partners....
Corebridge Financial’s $1.7 Billion Initial Public Offering
Wachtell, Lipton, Rosen & Katz represented AIG in the transaction, while Cleary Gottlieb represented the underwriters. Debevoise & Plimpton advised Corebridge Financial. American International Group, Inc....
Pfizer’s Acquisition of Global Blood Therapeutics
Wachtell, Lipton, Rosen & Katz represented Pfizer, while Cravath, Swaine & Moore and Goodwin Procter represented Global Blood Therapeutics in the transaction. Latham & Watkins represented the...
Blackstone’s Acquisition of 9.9% Equity Stake in AIG’s Life & Retirement Business
Wachtell, Lipton, Rosen & Katz and Debevoise & Plimpton served as legal advisor to AIG on the deal. Simpson Thacher and Bartlett LLP and Skadden, Arps,...
Agios’s $345 Million Repurchase Agreement With Bristol-Myers Squibb Company
Wachtell, Lipton, Rosen & Katz advised Agios Pharmaceuticals on the deal. Agios Pharmaceuticals, Inc. entered into a Share Repurchase Agreement with Bristol-Myers Squibb Company, pursuant to...